T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
New York Times
NYT
$10.3B
| $136M | 0.03% |
10,325,200
-45,900
| -0.4% | -$591K |
|
527
Teledyne Technologies
TDY
$31.8B
| $135M | 0.03% |
1,318,463
-170,310
| -11% | -$17.2M |
|
528
Middleby
MIDD
$5.38B
| $134M | 0.03% |
1,350,323
-138,884
| -9% | -$12.7M |
|
529
Cameco
CCJ
$43.1B
| $133M | 0.03% |
8,123,880
+143,780
| +2% | +$2.47M |
|
530
KBR
KBR
$4.8B
| $133M | 0.03% |
7,851,340
+2,056,340
| +35% | +$36.9M |
|
|
XLRN
531
DELISTED
Acceleron Pharma
XLRN
| $133M | 0.03% |
3,411,375
+176,320
| +5% | +$6.15M |
|
|
TRNX
532
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $133M | 0.03% |
5,205,599
+93,009
| +2% | +$2.37M |
|
|
TMH
533
DELISTED
Team Health Holdings Inc
TMH
| $132M | 0.03% |
2,301,544
-2,926
| -0.1% | -$169K |
|
|
ELME
534
Elme Communities
ELME
$144M
| $132M | 0.03% |
4,780,720
+181,520
| +4% | +$4.93M |
|
535
American International
AIG
$39.8B
| $132M | 0.03% |
2,356,914
+5,930
| +0.3% | +$318K |
|
536
Steel Dynamics
STLD
$37.7B
| $132M | 0.03% |
6,680,142
+1,382,527
| +26% | +$29.8M |
|
|
DPLO
537
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $132M | 0.03% |
+4,955,678
| New | +$120M |
|
538
NorthWestern Energy
NWE
$4.34B
| $131M | 0.03% |
2,318,335
+48,330
| +2% | +$2.52M |
|
539
NXP Semiconductors
NXPI
$58.9B
| $131M | 0.03% |
1,715,115
-3,884,810
| -69% | -$275M |
|
540
Assured Guaranty
AGO
$3.29B
| $130M | 0.03% |
5,013,861
+54,600
| +1% | +$1.32M |
|
541
Strategic Education
STRA
$1.81B
| $130M | 0.03% |
1,751,530
-147,025
| -8% | -$10.4M |
|
542
Petrobras Class A
PBR.A
$103B
| $129M | 0.03% |
17,044,779
-427,990
| -2% | -$4.83M |
|
|
ARUN
543
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $129M | 0.03% |
7,099,081
-905,618
| -11% | -$18.1M |
|
544
Halliburton
HAL
$27.7B
| $129M | 0.03% |
3,275,936
+568,125
| +21% | +$27.7M |
|
545
Westamerica Bancorp
WABC
$1.38B
| $129M | 0.03% |
2,628,233
-9,695
| -0.4% | -$466K |
|
|
TFCF
546
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $128M | 0.03% |
3,460,640
-4,734,200
| -58% | -$161M |
|
|
ESRX
547
DELISTED
Express Scripts Holding Company
ESRX
| $128M | 0.03% |
1,505,971
-48,390
| -3% | -$3.78M |
|
|
NBIS
548
Nebius Group N.V.
NBIS
$65.8B
| $127M | 0.03% |
7,052,493
+610,110
| +9% | +$14.7M |
|
549
Yum! Brands
YUM
$41B
| $126M | 0.03% |
2,412,957
+88,878
| +4% | +$4.63M |
|
|
WLL
550
DELISTED
Whiting Petroleum Corporation
WLL
| $126M | 0.03% |
12,753
+7,984
| +167% | +$122M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.